Long-term efficacy and safety of microwave ablation for hepatocellular carcinoma adjacent to the gallbladder with a diameter ≤ 5 cm: a multicenter, propensity score matching study-Reference-Cited by-全球学者库

Long-term efficacy and safety of microwave ablation for hepatocellular carcinoma adjacent to the gallbladder with a diameter ≤ 5 cm: a multicenter, propensity score matching study

Published:2023-08-22 Issue:1 Volume:40 Page:
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Li Lijuan¹²,Yao Jundong¹²,Yan Xizi¹²,Qi Xiaoguang¹,Liang Ping³,Han Zhiyu³,Liu Fangyi³,Cheng Zhigang³,Luo Yanchun³,Zheng Rongqin⁴,Cheng Wen⁵,Wei Qiang⁶,Yu Songyuan⁷,Yu Jie³^ORCID,Yu Xiaoling¹^ORCID

Affiliation:

1. Department of Interventional Ultrasound, the First Medical Center of Chinese PLA General Hospital, Beijing, China

2. Medical School of Chinese PLA, Beijing, China

3. Department of Ultrasound, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China

4. Department of Medical Ultrasonics, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

5. Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China

6. Department of Ultrasound, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China

7. Department of Ultrasound, Wuhan University of Science and Technology, Tianyou Hospital, Wuhan, China

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2023.2248425

Reference43 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Hepatocellular carcinoma

3. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring

4. Liver Transplantation for Acute Liver Failure

5. Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK